This approach offers several key advantages, including higher throughput, improved assay accuracy, reduced sample requirements, greater cost efficiency, and deeper insights into complex biological ...
Antibody therapeutics are a dominating feature of the current drug development landscape, but increasing costs and time-consuming workflows represent major barriers to their discovery and development.